Perineal tearing affects up to 90% of women birthing vaginally. It is painful and costly, estimated at over $10 billion annually in the US alone and for too long it has been accepted as an inevitable part of childbirth. We don't accept that.
Peripear is developing a wearable medical device that translates an evidence-based midwifery intervention, warm compress application during the second stage of labour, into a consistent, hands-free clinical tool which is designed to reduce perineal tearing at the moment it most commonly occurs.

We are backed by InnovateUK, 85% through our pre-seed round and in active conversation with US health systems about pilot partnerships. Our functional prototype is complete and was built in under two months.

Behind Peripear are two founders with complementary depth. Nina brings 14 years of NHS and private midwifery practice with direct experience of the clinical gap this device is designed to address. Eviatar brings over a decade of healthtech leadership, having raised more than $75M and scaled MedTech companies from concept to market as CXO, supported by a PhD from the University of Cambridge and a visiting scholarship at MIT.

We are building toward US hospital pilots, clinical evidence generation and long-term integration into standard perinatal care. If you are an investor, clinical innovator or health system leader who believes maternity care deserves better tools, we'd always welcome a conversation.

Peripear Ltd

Org chart

Teams

Offices